ILD: Health Outcomes in Remote Digital Monitoring versus Usual Care
Research type
Research Study
Full title
Comparison of health outcomes in a remote monitoring programme versus usual care in Interstitial Lung Disease
IRAS ID
301636
Contact name
Keith Boland
Contact email
Sponsor organisation
Imperial College Healthcare Trust
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 11 months, 31 days
Research summary
Interstitial lung disease (ILD) is a collective term for a group of diseases where the lungs become inflamed and/or scarred and this causes breathlessness.
This research project will assess if remote digital monitoring of frequent spirometry and pulse oximetry can provide an additional way to monitor ILD and provide information to support virtual consultations. Outcomes in the remote monitoring group will be compared with usual care alone over 12 months. Patients taking part will be randomly allocated to remote digital monitoring or to usual care (with an equal chance of either).
Remote monitoring will be performed using an app provided by patientMpower Ltd which patients will be able to download onto a smartphone or tablet. We will provide devices (spirometer and oximeter- both CE marked and used within their intended use) for patients to measure their lung function and oxygen saturation and spirometry. These devices link to the app via Bluetooth to record all measurements. will be asked to do these measurements twice a week and these results will be immediately visible. Previous studies of remote monitoring with at-home spirometry have shown that patients with ILD are willing and able to use similar devices and applications.
The study will assess patient and clinician opinions, patient engagement and frequency of use of the application, health-related quality of life and mental health (particularly health- related anxiety) using questionnaires. The study will investigate whether there are any clinical benefits such as whether remote monitoring can identify people earlier who are becoming more unwell. We are working with a health economist to analyse the outcomes from an economic perspective.
We are working with the national charity Action for Pulmonary Fibrosis to ensure that patient opinion and input is considered at every stage in this project.
REC name
London - Camden & Kings Cross Research Ethics Committee
REC reference
22/LO/0309
Date of REC Opinion
30 Jun 2022
REC opinion
Further Information Favourable Opinion